$Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review$

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review

BackgroundWe aimed to compare the efficacy of chimeric antigen receptor T (CAR-T) cell therapy with that of autologous stem cell transplantation (auto-HSCT) in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL).Research design and methodsWe searched eligible publications up to January 31s...

Descripció completa

Dades bibliogràfiques
Autors principals:	Linyan Tian, Cheng Li, Juan Sun, Yixin Zhai, Jinhuan Wang, Su Liu, Yanan Jiang, Wenqi Wu, Donghui Xing, Yangyang Lv, Jing Guo, Hong Xu, Huimeng Sun, Yuhang Li, Lanfang Li, Zhigang Zhao
Format:	Article
Idioma:	English
Publicat:	Frontiers Media S.A. 2023-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	R/R DLBCL CAR-T cell auto-HSCT survival meta-analysis
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041177/full

Ítems similars

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
per: Wenqi Wu, et al.
Publicat: (2023-01-01)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
per: Wenqi Wu, et al.
Publicat: (2023-06-01)

Evaluation of outcome and safety profile in high-dose BEAM and Benda-EAM chemotherapy with subsequent autologous stem cell transplantation in lymphoma patients
per: Kinga Krawiec, et al.
Publicat: (2024-07-01)

Pretransplant hypoalbuminemia may be associated with poor survival in patients that underwent autologous hematopoietic stem cell transplantation (autoHSCT)
per: Serdar Sivgin, et al.
Publicat: (2014-08-01)

Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
per: Zhen Li, et al.
Publicat: (2023-07-01)

Association of smoking with disease progression in persons with multiple sclerosis undergoing autologous hematopoietic cell transplantation: a single-center experience
per: Danitza Fernandez-Lara, et al.
Publicat: (2024-01-01)

Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
per: Narendranath Epperla, et al.
Publicat: (2025-01-01)

The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
per: Zhipeng Li, et al.
Publicat: (2024-04-01)

R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma
per: Mishima Yuko, et al.
Publicat: (2012-09-01)

Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study
per: Fatemeh Riasi, et al.
Publicat: (2023-12-01)

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma
per: Qian Fan, et al.
Publicat: (2016-11-01)

Evaluation of the Effects of R-CHOP Chemotherapy on Brain Glucose Metabolism in Patients with Diffuse Large B Cell Lymphoma: A Baseline, Interim, and End-of-Treatment PET/CT Study
per: Haiyan Zhu, et al.
Publicat: (2022-10-01)

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
per: Hong Xu, et al.
Publicat: (2022-06-01)

Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
per: Wei Sang, et al.
Publicat: (2020-08-01)

Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy
per: Mengya Cong, et al.
Publicat: (2024-01-01)

Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature
per: N G GABEEVA, et al.
Publicat: (2018-07-01)

MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma
per: Yangyang Xu, et al.
Publicat: (2020-11-01)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
per: Nan Yan, et al.
Publicat: (2021-07-01)

Prognostic value of interim PET/CT in GCB and non-GCB DLBCL: comparison of the Deauville five-point scale and the ΔSUVmax method
per: Na Sun, et al.
Publicat: (2024-12-01)

Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era
per: Wei‐Li Ma, et al.
Publicat: (2024-01-01)

From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives
per: Elisaveta Voynova, et al.
Publicat: (2021-10-01)

The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma
per: Epameinondas Koumpis, et al.
Publicat: (2024-11-01)

Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
per: Johanna Vets, et al.
Publicat: (2023-04-01)

PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients
per: M V Solovev, et al.
Publicat: (2019-07-01)

Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
per: Xiangxiang Zhou, et al.
Publicat: (2020-06-01)

Primary Bone Marrow Diffuse Large B-Cell Lymphoma in a frail and older patient: long lasting remission by R-CHOP
per: Pasquale Niscola
Publicat: (2014-08-01)

Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients
per: Wenyu Zhao, et al.
Publicat: (2024-02-01)

EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
per: Pellegrino Musto, et al.
Publicat: (2024-08-01)

MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy
per: Chen Yang, et al.
Publicat: (2018-10-01)

c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma
per: Antonin Bouroumeau, et al.
Publicat: (2021-11-01)

Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma
per: Karolina Piechna, et al.
Publicat: (2022-10-01)

Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix
per: Hiroko Murata, et al.
Publicat: (2020-08-01)

Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study
per: Danqi Luo, et al.
Publicat: (2024-04-01)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
per: Yanan Jiang, et al.
Publicat: (2022-06-01)

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
per: Gohar S. Manzar, et al.
Publicat: (2025-01-01)

Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation
per: Ying Jiang, et al.
Publicat: (2024-04-01)

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT
per: Ulrike Bacher, et al.
Publicat: (2023-04-01)

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience
per: Kristina Sonnevi, et al.
Publicat: (2021-11-01)

Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
per: Jiaqi Cui, et al.
Publicat: (2022-09-01)

Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
per: Guido Lancman, et al.
Publicat: (2018-01-01)